Cellular senescence — the irreversible growth arrest that drives tissue aging and age-related disease — has long been characterized through elastic mechanical properties like stiffness. This review synthesizes emerging evidence that the viscous component of cell mechanics, governing molecular transport, organelle mobility, and force dissipation, changes distinctly during senescence through cytoskeletal remodeling, macromolecular crowding, and intracellular phase separation, and may serve as a more sensitive diagnostic signature than elastic properties alone.
The significance here lies in a meaningful conceptual reframe. Most mechanobiology research has fixated on cellular stiffness as the readout of aging and disease. Viscosity, by contrast, reflects how energy dissipates inside cells — a fundamentally different biophysical dimension that correlates with molecular crowding and phase transitions increasingly linked to proteostasis collapse in aging tissues. If viscous property shifts precede or are orthogonal to stiffness changes, they could enable earlier detection of senescent cell burden — a key goal given that senolytic therapies (drugs that selectively eliminate senescent cells) are advancing through clinical trials and require reliable biomarkers to guide dosing and efficacy assessment.
Critically, this is a review, not primary data, so it synthesizes rather than generates novel findings. The field still lacks standardized measurement protocols and in vivo validation. Translating intracellular viscosity measurements from atomic force microscopy or optical tweezers into clinically actionable tools remains a substantial engineering challenge. Nonetheless, this represents a conceptually important frontier worth watching closely.
